{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381418519086786436.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Morris Zwi"}],"foaf:familyName":[{"@value":"Zwi"}],"foaf:givenName":[{"@value":"Morris"}]}],"career":[{"institution":{"notation":[{"@value":"Whittington Health; Islington Child and Adolescent Mental Health Service; 580 Holloway Road London London UK N7 6LB"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361418519086786432","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1002/14651858.cd009885.pub2"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full/10.1002/14651858.CD009885.pub2"}],"notation":[{"@value":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/14651858.cd009885.pub2_6HyS9uTD2hYmNGChfTu6mMA7qJv"}]}